Bicycle Therapeutics Plc (BCYC)
4.34
-0.03
(-0.69%)
USD |
NASDAQ |
Aug 24, 16:00
4.42
+0.08
(+1.84%)
After-Hours: 20:00
Bicycle Therapeutics Total Assets (Quarterly) : 606.58M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 606.58M |
| March 31, 2026 | 652.40M |
| December 31, 2025 | 717.60M |
| September 30, 2025 | 763.95M |
| June 30, 2025 | 832.18M |
| March 31, 2025 | 883.89M |
| December 31, 2024 | 956.87M |
| September 30, 2024 | 996.75M |
| June 30, 2024 | 1.057B |
| March 31, 2024 | 547.14M |
| December 31, 2023 | 595.34M |
| September 30, 2023 | 638.68M |
| June 30, 2023 | 454.17M |
| March 31, 2023 | 428.80M |
| December 31, 2022 | 410.61M |
| September 30, 2022 | 417.15M |
| June 30, 2022 | 445.48M |
| March 31, 2022 | 459.56M |
| Date | Value |
|---|---|
| December 31, 2021 | 479.79M |
| September 30, 2021 | 281.33M |
| June 30, 2021 | 226.05M |
| March 31, 2021 | 223.84M |
| December 31, 2020 | 161.15M |
| September 30, 2020 | 170.06M |
| June 30, 2020 | 118.60M |
| March 31, 2020 | 129.28M |
| December 31, 2019 | 110.19M |
| September 30, 2019 | 116.06M |
| June 30, 2019 | 126.25M |
| March 31, 2019 | 77.79M |
| December 31, 2018 | 81.63M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 73.93M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Autolus Therapeutics Plc | 493.23M |
| Akari Therapeutics Plc | 38.62M |
| Biodexa Pharmaceuticals Plc | -- |
| DBV Technologies SA | -- |
| Cellectis SA | 267.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 96.32M |
| Shareholders Equity (Quarterly) | 510.26M |
| Debt to Equity Ratio | 0.0298 |
| Current Ratio | 12.08 |
| Net Debt Paydown Yield | -0.57% |